March 5, 2019, HemOnc Today 

Cryoablation may be an effective primary treatment option for women with low-risk breast cancer, according to preliminary findings from the Ice 3 trial. The trial included women aged 60 years and older who underwent cryoablation across 20 centers in the U.S. for low-risk breast cancer. Researchers will use mammography to monitor the women for breast cancer recurrence at 6 months and 12 months, and then annually for 5 years. 

Read more.